Pelletier J, Thomas G, Volarević S. Ribosome biogenesis in cancer: new players and therapeutic avenues. Nat Rev Cancer. 2018;18:51–63.
Google Scholar
Bursać S, Prodan Y, Pullen N, Bartek J, Volarević S. Dysregulated ribosome biogenesis reveals therapeutic liabilities in cancer. Trends Cancer. 2021;7:57–76.
Google Scholar
Ebright RY, Lee S, Wittner BS, Niederhoffer KL, Nicholson BT, Bardia A, et al. Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis. Science. 2020;367:1468–73.
Google Scholar
Xie J, Zhang W, Liang X, Shuai C, Zhou Y, Pan H, et al. RPL32 promotes lung cancer progression by facilitating p53 degradation. Mol Ther Nucleic Acids. 2020;21:75–85.
Google Scholar
Luo S, Zhao J, Fowdur M, Wang K, Jiang T, He M. Highly expressed ribosomal protein L34 indicates poor prognosis in osteosarcoma and its knockdown suppresses osteosarcoma proliferation probably through translational control. Sci Rep. 2016;6:37690.
Google Scholar
Yang S, Cui J, Yang Y, Liu Z, Yan H, Tang C, et al. Over-expressed RPL34 promotes malignant proliferation of non-small cell lung cancer cells. Gene. 2016;576:421–8.
Google Scholar
Dai J, Wei W. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells. Arch Oral Biol. 2017;83:40–46.
Google Scholar
Ji P, Wang L, Liu J, Mao P, Li R, Jiang H, et al. Knockdown of RPL34 inhibits the proliferation and migration of glioma cells through the inactivation of JAK/STAT3 signaling pathway. J Cell Biochem. 2019;120:3259–67.
Google Scholar
Simsek D, Tiu GC, Flynn RA, Byeon GW, Leppek K, Xu AF, et al. The mammalian ribo-interactome reveals ribosome functional diversity and heterogeneity. Cell. 2017;169:1051–1065.e1018.
Google Scholar
Martínez-Férriz A, Ferrando A, Fathinajafabadi A, Farràs R. Ubiquitin-mediated mechanisms of translational control. Semin Cell Dev Biol. 2022;132:146–54.
Google Scholar
Meyer C, Garzia A, Morozov P, Molina H, Tuschl T. The G3BP1-family-USP10 deubiquitinase complex rescues ubiquitinated 40S subunits of ribosomes stalled in translation from lysosomal degradation. Mol Cell. 2020;77:1193–1205.e1195.
Google Scholar
Garzia A, Meyer C, Tuschl T. The E3 ubiquitin ligase RNF10 modifies 40S ribosomal subunits of ribosomes compromised in translation. Cell Rep. 2021;36:109468.
Google Scholar
Wang T, Jin C, Yang P, Chen Z, Ji J, Sun Q, et al. UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3. Oncogene. 2023;42:651–64.
Google Scholar
Liao Y, Shao Z, Liu Y, Xia X, Deng Y, Yu C, et al. USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2021;40:201.
Google Scholar
Garcia-Gonzalo FR, Rosa JL. The HERC proteins: functional and evolutionary insights. Cell Mol Life Sci. 2005;62:1826–38.
Google Scholar
Hochrainer K, Mayer H, Baranyi U, Binder B, Lipp J, Kroismayr R. The human HERC family of ubiquitin ligases: novel members, genomic organization, expression profiling, and evolutionary aspects. Genomics. 2005;85:153–64.
Google Scholar
Zhang Z, Tong J, Tang X, Juan J, Cao B, Hurren R, et al. The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice. Blood. 2016;127:1676–86.
Google Scholar
Zhang Z, Li M, Lin P, Ren Y, He Y, Wang S, et al. The ubiquitin ligase HERC4 suppresses MafA transcriptional activity triggered by GSK3β in myeloma by atypical K63-linked polyubiquitination. J Biol Chem. 2023;299:104675.
Google Scholar
Xu Y, Ji K, Wu M, Hao B, Yao KT, Xu Y. A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1. Protein Cell. 2019;10:595–605.
Google Scholar
Zheng Y, Li J, Pan C, Zhou G, Zhuge L, Jin L, et al. HERC4 is overexpressed in hepatocellular carcinoma and contributes to the proliferation and migration of hepatocellular carcinoma cells. DNA Cell Biol. 2017;36:490–500.
Google Scholar
Jiang S, Wang X, He Y, Huang H, Cao B, Zhang Z, et al. Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis. Cell Death Dis. 2021;12:456.
Google Scholar
Zhuang H, Ren Y, Mao C, Zhong Y, Zhang Z, Cao B, et al. Induction of zinc finger protein RNF6 auto-ubiquitination for the treatment of myeloma and chronic myeloid leukemia. J Biol Chem. 2022;298:102314.
Google Scholar
He Y, Jiang S, Mao C, Zheng H, Cao B, Zhang Z, et al. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation. J Biol Chem. 2021;297:101088.
Google Scholar
Ge J, Yu W, Li J, Ma H, Wang P, Zhou Y, et al. USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc. J Exp Clin Cancer Res. 2021;40:59.
Google Scholar
Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS. Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance. Cancer Res. 2022;82:2344–53.
Google Scholar
Bretones G, Álvarez MG, Arango JR, Rodríguez D, Nadeu F, Prado MA, et al. Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia. Blood. 2018;132:2375–88.
Google Scholar
Ntoufa S, Gerousi M, Laidou S, Psomopoulos F, Tsiolas G, Moysiadis T, et al. RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia. Blood Adv. 2021;5:2788–92.
Google Scholar
Zhao Y, Li Y, Zhu R, Feng R, Cui H, Yu X, et al. RPS15 interacted with IGF2BP1 to promote esophageal squamous cell carcinoma development via recognizing m(6)A modification. Signal Transduct Target Ther. 2023;8:224.
Google Scholar
Deisenroth C, Zhang Y. Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway. Oncogene. 2010;29:4253–60.
Google Scholar
Liu M, Zhao Z, Wang C, Sang S, Cui Y, Lv C, et al. Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells. Cancer Lett. 2024;594:216991.
Google Scholar
Zeng WL, Chen YW, Zhou H, Zhou JY, Wei M, Shi R. Expression of HERC4 in lung cancer and its correlation with clinicopathological parameters. Asian Pac J Cancer Prev. 2015;16:513–7.
Google Scholar
Ljungström V, Cortese D, Young E, Pandzic T, Mansouri L, Plevova K, et al. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations. Blood. 2016;127:1007–16.
Google Scholar
Ford PW, Narasimhan M, Bennett EJ. Ubiquitin-dependent translation control mechanisms: Degradation and beyond. Cell Rep. 2024;43:115050.
Google Scholar
Zhang Z, Wu Q, Fang M, Liu Y, Jiang J, Feng Q, et al. HERC3 directly targets RPL23A for ubiquitination degradation and further regulates Colorectal Cancer proliferation and the cell cycle. Int J Biol Sci. 2022;18:3282–97.
Google Scholar
Durfee LA, Lyon N, Seo K, Huibregtse JM. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell. 2010;38:722–32.
Google Scholar
Zheng J, Chen C, Guo C, Caba C, Tong Y, Wang H. The pleiotropic ubiquitin-specific peptidase 16 and its many substrates. Cells. 2023;12:886.
Liu S, Li H, Zhu Y, Ma X, Shao Z, Yang Z, et al. LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer. Cancer Lett. 2022;547:215862.
Google Scholar
Xu G, Yang Z, Ding Y, Liu Y, Zhang L, Wang B, et al. The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis. Oncogene. 2021;40:5482–94.
Google Scholar
Luan Y, Tang N, Yang J, Liu S, Cheng C, Wang Y, et al. Deficiency of ribosomal proteins reshapes the transcriptional and translational landscape in human cells. Nucleic Acids Res. 2022;50:6601–17.
Google Scholar
Liu Y, Deisenroth C, Zhang Y. RP-MDM2-p53 pathway: linking ribosomal biogenesis and tumor surveillance. Trends Cancer. 2016;2:191–204.
Google Scholar
